Zambia Launches Long-Acting HIV Prevention Drug By Honester Mshoka Zambia has launched the new long-acting pre-exposure prophylaxis -PrEP, Lenacapavir, bringing renewed hope to young people and other vulnerable populations. The Pre-Exposure Prophylaxis option provides six months of protection with a single dose for individuals who are HIV-negative. Health Minister ELIJAH MUCHIMA says the introduction of Lenacapavir marks Zambia’s leadership in the global AIDS response and shows the country’s abi

PrEP: Pre-exposure Prophylaxis (PrEP), a once a day medication that PREVENTS HIV. Without prevention, HIV, without treatment can lead to AIDS. PrEP has been proven to be 99% effective at preventing HIV when taken as prescribed. Spread the word. #WorldAIDSDay #TheBLACKMedia | The BLACK Media

Prevention is essential to helping end the #HIV epidemic, and PrEP (pre-exposure prophylaxis) is a key piece of the puzzle. At Gilead, we’re working to turn possibility into progress as we strive to reach more people with new PrEP options. | Gilead Sciences | Facebook